

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.71140694 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.71140694 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.59570824 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.17742795 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.73663696 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.46044663 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.46044663 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.46044663 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.46044663 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.46044663 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.46044663 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.34024588 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.32558548 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.19668952 |
| 15 | detection of other organism (GO:0098543) | 4.00689631 |
| 16 | detection of bacterium (GO:0016045) | 3.96595063 |
| 17 | positive thymic T cell selection (GO:0045059) | 3.92984173 |
| 18 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.70977876 |
| 19 | negative T cell selection (GO:0043383) | 3.70219095 |
| 20 | response to interleukin-15 (GO:0070672) | 3.69404025 |
| 21 | negative thymic T cell selection (GO:0045060) | 3.59943565 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.58590269 |
| 23 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.58056398 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.55636974 |
| 25 | neutrophil activation (GO:0042119) | 3.55611527 |
| 26 | thymic T cell selection (GO:0045061) | 3.46800895 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38670461 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.38670461 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.34590742 |
| 30 | morphogenesis of an endothelium (GO:0003159) | 3.34325424 |
| 31 | endothelial tube morphogenesis (GO:0061154) | 3.34325424 |
| 32 | regulation of B cell differentiation (GO:0045577) | 3.30384981 |
| 33 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.30366584 |
| 34 | regulation of T cell tolerance induction (GO:0002664) | 3.28208403 |
| 35 | leukocyte aggregation (GO:0070486) | 3.27043404 |
| 36 | B cell receptor signaling pathway (GO:0050853) | 3.24700407 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.22074348 |
| 38 | detection of external biotic stimulus (GO:0098581) | 3.20471689 |
| 39 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.19705958 |
| 40 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.17323212 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.17243668 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.16741420 |
| 43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.14783506 |
| 44 | positive T cell selection (GO:0043368) | 3.13905583 |
| 45 | T cell selection (GO:0045058) | 3.13569877 |
| 46 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.11367206 |
| 47 | angiogenesis involved in wound healing (GO:0060055) | 3.08983394 |
| 48 | granulocyte activation (GO:0036230) | 3.08757732 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.07335324 |
| 50 | cellular response to interleukin-15 (GO:0071350) | 3.02058110 |
| 51 | negative regulation of phagocytosis (GO:0050765) | 3.01382440 |
| 52 | definitive hemopoiesis (GO:0060216) | 3.00446738 |
| 53 | response to muramyl dipeptide (GO:0032495) | 2.99100649 |
| 54 | cellular extravasation (GO:0045123) | 2.96258630 |
| 55 | response to host (GO:0075136) | 2.96245733 |
| 56 | response to host defenses (GO:0052200) | 2.96245733 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96245733 |
| 58 | regulation of mast cell degranulation (GO:0043304) | 2.95778042 |
| 59 | response to host immune response (GO:0052572) | 2.93776947 |
| 60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.93776947 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.93710776 |
| 62 | signal complex assembly (GO:0007172) | 2.93327671 |
| 63 | respiratory burst (GO:0045730) | 2.88266434 |
| 64 | interferon-gamma production (GO:0032609) | 2.87613988 |
| 65 | positive regulation of tolerance induction (GO:0002645) | 2.84988084 |
| 66 | megakaryocyte development (GO:0035855) | 2.83324758 |
| 67 | positive regulation of histone deacetylation (GO:0031065) | 2.81350322 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 2.81069615 |
| 69 | natural killer cell differentiation (GO:0001779) | 2.80916930 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.80481759 |
| 71 | positive regulation of lamellipodium assembly (GO:0010592) | 2.79207641 |
| 72 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.78354231 |
| 73 | detection of biotic stimulus (GO:0009595) | 2.77768324 |
| 74 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.71050230 |
| 75 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.70990043 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.70990043 |
| 77 | detection of molecule of bacterial origin (GO:0032490) | 2.68157700 |
| 78 | response to peptidoglycan (GO:0032494) | 2.68063130 |
| 79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.67758405 |
| 80 | regulation of defense response to virus by virus (GO:0050690) | 2.67251674 |
| 81 | T cell migration (GO:0072678) | 2.66378762 |
| 82 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.66330995 |
| 83 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.65784830 |
| 84 | activated T cell proliferation (GO:0050798) | 2.65684455 |
| 85 | regulation of response to interferon-gamma (GO:0060330) | 2.65682979 |
| 86 | dendritic cell chemotaxis (GO:0002407) | 2.65572126 |
| 87 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.65001274 |
| 88 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.64229110 |
| 89 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.63882297 |
| 90 | negative regulation of T cell mediated immunity (GO:0002710) | 2.63507700 |
| 91 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.63234210 |
| 92 | positive regulation of receptor recycling (GO:0001921) | 2.63045540 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.62851156 |
| 94 | T cell homeostasis (GO:0043029) | 2.61853053 |
| 95 | hepatocyte apoptotic process (GO:0097284) | 2.61822500 |
| 96 | response to laminar fluid shear stress (GO:0034616) | 2.60957579 |
| 97 | regulation of platelet aggregation (GO:0090330) | 2.59541513 |
| 98 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.58698569 |
| 99 | T cell costimulation (GO:0031295) | 2.58174288 |
| 100 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.57955380 |
| 101 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.57072623 |
| 102 | regulation of extracellular matrix disassembly (GO:0010715) | 2.56403250 |
| 103 | dendritic cell migration (GO:0036336) | 2.55313862 |
| 104 | leukocyte cell-cell adhesion (GO:0007159) | 2.55274277 |
| 105 | positive regulation of lamellipodium organization (GO:1902745) | 2.54608042 |
| 106 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.54110237 |
| 107 | T cell receptor signaling pathway (GO:0050852) | 2.54100856 |
| 108 | negative regulation of type 2 immune response (GO:0002829) | 2.53919168 |
| 109 | negative regulation of stress fiber assembly (GO:0051497) | 2.53817312 |
| 110 | regulation of tolerance induction (GO:0002643) | 2.53085171 |
| 111 | negative regulation of innate immune response (GO:0045824) | 2.51888943 |
| 112 | positive regulation of mast cell activation (GO:0033005) | 2.51721182 |
| 113 | lymphocyte costimulation (GO:0031294) | 2.51605265 |
| 114 | germ cell migration (GO:0008354) | 2.51513582 |
| 115 | positive regulation of protein deacetylation (GO:0090312) | 2.51503469 |
| 116 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.51382140 |
| 117 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.47408553 |
| 118 | myeloid cell activation involved in immune response (GO:0002275) | 2.47278260 |
| 119 | tolerance induction (GO:0002507) | 2.46835692 |
| 120 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.46730998 |
| 121 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.46627287 |
| 122 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.45311281 |
| 123 | mast cell activation (GO:0045576) | 2.42832918 |
| 124 | regulation of regulated secretory pathway (GO:1903305) | 2.42074821 |
| 125 | cellular response to zinc ion (GO:0071294) | 2.42006856 |
| 126 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.41661174 |
| 127 | blood vessel maturation (GO:0001955) | 2.41657214 |
| 128 | regulation of macrophage cytokine production (GO:0010935) | 2.41226702 |
| 129 | leukocyte degranulation (GO:0043299) | 2.41027184 |
| 130 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.39371368 |
| 131 | regulation of natural killer cell differentiation (GO:0032823) | 2.38722343 |
| 132 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.38569106 |
| 133 | response to type I interferon (GO:0034340) | 2.38384611 |
| 134 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.37954086 |
| 135 | regulation of necroptotic process (GO:0060544) | 2.37704894 |
| 136 | pinocytosis (GO:0006907) | 2.37471295 |
| 137 | NIK/NF-kappaB signaling (GO:0038061) | 2.37020585 |
| 138 | stress fiber assembly (GO:0043149) | 2.36202048 |
| 139 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35803450 |
| 140 | lymphocyte homeostasis (GO:0002260) | 2.35316201 |
| 141 | keratan sulfate catabolic process (GO:0042340) | 2.34954914 |
| 142 | embryonic hemopoiesis (GO:0035162) | 2.33293628 |
| 143 | lymph node development (GO:0048535) | 2.33223639 |
| 144 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.33199339 |
| 145 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.32353433 |
| 146 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.31643730 |
| 147 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.28511091 |
| 148 | type I interferon signaling pathway (GO:0060337) | 2.28472086 |
| 149 | cellular response to type I interferon (GO:0071357) | 2.28472086 |
| 150 | establishment of endothelial barrier (GO:0061028) | 2.25739236 |
| 151 | skin morphogenesis (GO:0043589) | 2.22466807 |
| 152 | germinal center formation (GO:0002467) | 2.20494370 |
| 153 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.18788538 |
| 154 | positive regulation of granulocyte differentiation (GO:0030854) | 2.18747640 |
| 155 | natural killer cell activation (GO:0030101) | 2.18649972 |
| 156 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.17700587 |
| 157 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.17700587 |
| 158 | cellular hyperosmotic response (GO:0071474) | 2.16651205 |
| 159 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.16594081 |
| 160 | positive regulation of interleukin-2 production (GO:0032743) | 2.14129486 |
| 161 | actin-myosin filament sliding (GO:0033275) | 2.13614524 |
| 162 | muscle filament sliding (GO:0030049) | 2.13614524 |
| 163 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.13075308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.66841078 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.30109500 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.72188436 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.49931344 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.47762539 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.21909834 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.08149629 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86093455 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.82085009 |
| 10 | * MAF_26560356_Chip-Seq_TH1_Human | 2.53201411 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.49335120 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.42628115 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.41776123 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.35028083 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31622246 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24622325 |
| 17 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.23086673 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22546902 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20549233 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19000790 |
| 21 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11997096 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.10332571 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06474717 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.02787475 |
| 25 | * MYB_26560356_Chip-Seq_TH1_Human | 2.01790365 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00309431 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99798795 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98999484 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98947272 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.94696477 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.94555423 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93420634 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88672279 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.85264174 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84600966 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84353738 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83798068 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82897697 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80507146 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76767476 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75163176 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73259580 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70985155 |
| 44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.69565863 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68861856 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63517958 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.62789914 |
| 48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.62300346 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.59951462 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.59313439 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.52530094 |
| 52 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47810827 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45703571 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.44117581 |
| 55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41487540 |
| 56 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41108111 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40902326 |
| 58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40525818 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38808785 |
| 60 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.38393743 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38344148 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37454822 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37345221 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36345294 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33679591 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30920850 |
| 67 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.29688159 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29668627 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28688721 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28381308 |
| 71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27669931 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27153962 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26497227 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.25054873 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24626384 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22735301 |
| 77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22579640 |
| 78 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22555885 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22117324 |
| 80 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21892904 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21032756 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20578604 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19047036 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18445489 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18112547 |
| 86 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.17103358 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16714300 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14643371 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12910846 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12545097 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12310211 |
| 92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12299281 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12068018 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11006304 |
| 95 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10798580 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09482454 |
| 97 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.09212928 |
| 98 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09206463 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09197350 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09156481 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08894378 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08790244 |
| 103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08309776 |
| 104 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07755342 |
| 105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07023503 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06804323 |
| 107 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06092874 |
| 108 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03496313 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03133152 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03085719 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03085719 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02879997 |
| 113 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01704682 |
| 114 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01704682 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00364218 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00307686 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99129813 |
| 118 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98951104 |
| 119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97786615 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97783491 |
| 121 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97555986 |
| 122 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96575384 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96199822 |
| 124 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.92959669 |
| 125 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92791548 |
| 126 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92752607 |
| 127 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92433387 |
| 128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91858009 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91420941 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90343084 |
| 131 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88901569 |
| 132 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88423800 |
| 133 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.85027546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 2.69574115 |
| 2 | MP0002396_abnormal_hematopoietic_system | 2.61956704 |
| 3 | MP0000685_abnormal_immune_system | 2.54516732 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.49803395 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.48626522 |
| 6 | MP0003279_aneurysm | 2.40932104 |
| 7 | MP0006054_spinal_hemorrhage | 2.37638509 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.37515354 |
| 9 | MP0008260_abnormal_autophagy | 2.27779033 |
| 10 | MP0002933_joint_inflammation | 2.23615537 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.23551393 |
| 12 | MP0001958_emphysema | 2.17238913 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.12272460 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 2.10538886 |
| 15 | MP0004381_abnormal_hair_follicle | 2.06878206 |
| 16 | MP0001800_abnormal_humoral_immune | 2.01972116 |
| 17 | MP0005671_abnormal_response_to | 1.97486173 |
| 18 | MP0004858_abnormal_nervous_system | 1.91777544 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 1.89220497 |
| 20 | MP0001790_abnormal_immune_system | 1.88319054 |
| 21 | MP0005387_immune_system_phenotype | 1.88319054 |
| 22 | MP0003436_decreased_susceptibility_to | 1.86807250 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.86141365 |
| 24 | MP0002398_abnormal_bone_marrow | 1.84322625 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.80989222 |
| 26 | MP0005503_abnormal_tendon_morphology | 1.80043162 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.77621819 |
| 28 | MP0001819_abnormal_immune_cell | 1.74320610 |
| 29 | MP0009278_abnormal_bone_marrow | 1.70591344 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.69775988 |
| 31 | MP0005275_abnormal_skin_tensile | 1.68265698 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 1.66079609 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.65479969 |
| 34 | MP0002723_abnormal_immune_serum | 1.64364288 |
| 35 | MP0003878_abnormal_ear_physiology | 1.63979969 |
| 36 | MP0005377_hearing/vestibular/ear_phenot | 1.63979969 |
| 37 | MP0005023_abnormal_wound_healing | 1.62328676 |
| 38 | MP0001873_stomach_inflammation | 1.58960677 |
| 39 | MP0003303_peritoneal_inflammation | 1.57192939 |
| 40 | MP0000716_abnormal_immune_system | 1.55258644 |
| 41 | MP0002405_respiratory_system_inflammati | 1.53955443 |
| 42 | MP0001849_ear_inflammation | 1.53909774 |
| 43 | MP0004947_skin_inflammation | 1.52234792 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.51610557 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.50928705 |
| 46 | MP0002132_abnormal_respiratory_system | 1.50670557 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.50018608 |
| 48 | MP0002722_abnormal_immune_system | 1.49752461 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.47638620 |
| 50 | MP0002006_tumorigenesis | 1.47603095 |
| 51 | MP0009785_altered_susceptibility_to | 1.47323119 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.46773433 |
| 53 | MP0005025_abnormal_response_to | 1.45788814 |
| 54 | MP0004084_abnormal_cardiac_muscle | 1.43497747 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.42439414 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.40493017 |
| 57 | MP0002419_abnormal_innate_immunity | 1.39564801 |
| 58 | MP0004883_abnormal_blood_vessel | 1.38882947 |
| 59 | MP0000733_abnormal_muscle_development | 1.38739722 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.37584911 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 1.37203780 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.37203014 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.37203014 |
| 64 | MP0002429_abnormal_blood_cell | 1.34865143 |
| 65 | MP0004510_myositis | 1.32661869 |
| 66 | MP0005451_abnormal_body_composition | 1.29120192 |
| 67 | MP0000343_altered_response_to | 1.27991837 |
| 68 | MP0000751_myopathy | 1.27803699 |
| 69 | MP0003091_abnormal_cell_migration | 1.25207681 |
| 70 | MP0000767_abnormal_smooth_muscle | 1.24999278 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.24456098 |
| 72 | MP0000858_altered_metastatic_potential | 1.22948314 |
| 73 | MP0005083_abnormal_biliary_tract | 1.20123893 |
| 74 | MP0005248_abnormal_Harderian_gland | 1.19327829 |
| 75 | MP0002796_impaired_skin_barrier | 1.19077428 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.18769862 |
| 77 | MP0003724_increased_susceptibility_to | 1.18043879 |
| 78 | MP0001853_heart_inflammation | 1.15870498 |
| 79 | MP0008004_abnormal_stomach_pH | 1.15732123 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 1.14292206 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 1.12134458 |
| 82 | MP0003828_pulmonary_edema | 1.11800090 |
| 83 | MP0003646_muscle_fatigue | 1.11790212 |
| 84 | MP0006082_CNS_inflammation | 1.05819330 |
| 85 | MP0003448_altered_tumor_morphology | 1.03821417 |
| 86 | MP0003045_fibrosis | 1.03591281 |
| 87 | MP0001845_abnormal_inflammatory_respons | 1.02658595 |
| 88 | MP0003172_abnormal_lysosome_physiology | 1.00678642 |
| 89 | MP0009384_cardiac_valve_regurgitation | 1.00069759 |
| 90 | MP0005390_skeleton_phenotype | 0.99695111 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.99664773 |
| 92 | MP0000750_abnormal_muscle_regeneration | 0.97674401 |
| 93 | MP0002060_abnormal_skin_morphology | 0.96848826 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.96745816 |
| 95 | MP0002254_reproductive_system_inflammat | 0.96601622 |
| 96 | MP0000749_muscle_degeneration | 0.96261522 |
| 97 | MP0004087_abnormal_muscle_fiber | 0.96163265 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.94777443 |
| 99 | MP0004130_abnormal_muscle_cell | 0.93046009 |
| 100 | MP0004134_abnormal_chest_morphology | 0.93011811 |
| 101 | MP0008007_abnormal_cellular_replicative | 0.92843879 |
| 102 | MP0000490_abnormal_crypts_of | 0.89977172 |
| 103 | MP0002133_abnormal_respiratory_system | 0.89928121 |
| 104 | MP0005388_respiratory_system_phenotype | 0.89928121 |
| 105 | MP0001851_eye_inflammation | 0.89894979 |
| 106 | MP0004036_abnormal_muscle_relaxation | 0.89405617 |
| 107 | MP0003866_abnormal_defecation | 0.89240690 |
| 108 | MP0010630_abnormal_cardiac_muscle | 0.88046703 |
| 109 | MP0000249_abnormal_blood_vessel | 0.88036408 |
| 110 | MP0010030_abnormal_orbit_morphology | 0.87958107 |
| 111 | MP0000747_muscle_weakness | 0.86357509 |
| 112 | MP0002128_abnormal_blood_circulation | 0.85814989 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.83925561 |
| 114 | MP0001243_abnormal_dermal_layer | 0.83858380 |
| 115 | MP0001663_abnormal_digestive_system | 0.83659410 |
| 116 | MP0001348_abnormal_lacrimal_gland | 0.83428512 |
| 117 | MP0003795_abnormal_bone_structure | 0.83237082 |
| 118 | MP0005164_abnormal_response_to | 0.82886260 |
| 119 | MP0005501_abnormal_skin_physiology | 0.82491568 |
| 120 | MP0002106_abnormal_muscle_physiology | 0.81755369 |
| 121 | MP0003329_amyloid_beta_deposits | 0.78066711 |
| 122 | MP0002925_abnormal_cardiovascular_devel | 0.78063370 |
| 123 | MP0008874_decreased_physiological_sensi | 0.77716450 |
| 124 | MP0000759_abnormal_skeletal_muscle | 0.77316525 |
| 125 | MP0008961_abnormal_basal_metabolism | 0.76317661 |
| 126 | MP0004272_abnormal_basement_membrane | 0.75986471 |
| 127 | MP0005508_abnormal_skeleton_morphology | 0.75252832 |
| 128 | MP0005058_abnormal_lysosome_morphology | 0.74807688 |
| 129 | MP0001915_intracranial_hemorrhage | 0.74753656 |
| 130 | MP0002113_abnormal_skeleton_development | 0.73439029 |
| 131 | MP0002877_abnormal_melanocyte_morpholog | 0.72253227 |
| 132 | MP0005310_abnormal_salivary_gland | 0.70509775 |
| 133 | MP0003690_abnormal_glial_cell | 0.69841054 |
| 134 | MP0005381_digestive/alimentary_phenotyp | 0.67698180 |
| 135 | MP0000377_abnormal_hair_follicle | 0.66376153 |
| 136 | MP0008469_abnormal_protein_level | 0.64635644 |
| 137 | MP0003075_altered_response_to | 0.63738079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 3.92017425 |
| 2 | Abnormality of macrophages (HP:0004311) | 3.75053621 |
| 3 | Orchitis (HP:0100796) | 3.50981514 |
| 4 | Aortic aneurysm (HP:0004942) | 3.33666200 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.18023643 |
| 6 | Abnormal platelet volume (HP:0011876) | 3.16613399 |
| 7 | Ulnar deviation of the wrist (HP:0003049) | 3.08364086 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.00370045 |
| 9 | Optic neuritis (HP:0100653) | 3.00370045 |
| 10 | Chronic otitis media (HP:0000389) | 2.92377259 |
| 11 | Cerebral aneurysm (HP:0004944) | 2.91315171 |
| 12 | Obstructive sleep apnea (HP:0002870) | 2.91076719 |
| 13 | Stomatitis (HP:0010280) | 2.86876633 |
| 14 | Epiphyseal dysplasia (HP:0002656) | 2.86112835 |
| 15 | Petechiae (HP:0000967) | 2.81945601 |
| 16 | Epistaxis (HP:0000421) | 2.76761095 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 2.74269655 |
| 18 | Recurrent bronchitis (HP:0002837) | 2.71970831 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 2.68525927 |
| 20 | Abnormality of the nasal mucosa (HP:0000433) | 2.68293449 |
| 21 | Meningitis (HP:0001287) | 2.68102224 |
| 22 | Spondylolisthesis (HP:0003302) | 2.65783667 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65434964 |
| 24 | Obstructive lung disease (HP:0006536) | 2.65434964 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.64056306 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.63928508 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 2.63269406 |
| 28 | Peritonitis (HP:0002586) | 2.63041250 |
| 29 | Gingivitis (HP:0000230) | 2.57507913 |
| 30 | Absent frontal sinuses (HP:0002688) | 2.56733884 |
| 31 | Abnormality of the fingertips (HP:0001211) | 2.55603056 |
| 32 | Broad face (HP:0000283) | 2.55246170 |
| 33 | Hematochezia (HP:0002573) | 2.54872865 |
| 34 | Aortic dissection (HP:0002647) | 2.54459377 |
| 35 | Ankle contracture (HP:0006466) | 2.52623993 |
| 36 | Broad metatarsal (HP:0001783) | 2.52270558 |
| 37 | Gingival bleeding (HP:0000225) | 2.52123820 |
| 38 | Increased mean platelet volume (HP:0011877) | 2.51008111 |
| 39 | Myositis (HP:0100614) | 2.50993689 |
| 40 | Recurrent viral infections (HP:0004429) | 2.50419668 |
| 41 | Cervical subluxation (HP:0003308) | 2.50392195 |
| 42 | Menorrhagia (HP:0000132) | 2.49517364 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.48020219 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.47009106 |
| 45 | Hypoplastic ischia (HP:0003175) | 2.46873943 |
| 46 | Purpura (HP:0000979) | 2.44272090 |
| 47 | Thrombocytosis (HP:0001894) | 2.43617203 |
| 48 | T lymphocytopenia (HP:0005403) | 2.39831618 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.39298210 |
| 50 | Metaphyseal cupping (HP:0003021) | 2.38328700 |
| 51 | Small epiphyses (HP:0010585) | 2.36541184 |
| 52 | Chest pain (HP:0100749) | 2.35890548 |
| 53 | Abnormality of the calcaneus (HP:0008364) | 2.34481333 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.33571273 |
| 55 | Nasal polyposis (HP:0100582) | 2.33257862 |
| 56 | Cellulitis (HP:0100658) | 2.33103953 |
| 57 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.32398106 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 2.31250599 |
| 59 | Muscle fiber inclusion bodies (HP:0100299) | 2.30704716 |
| 60 | Lumbar hyperlordosis (HP:0002938) | 2.29222798 |
| 61 | Increased density of long bones (HP:0006392) | 2.28386220 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.26950279 |
| 63 | Spinal cord lesions (HP:0100561) | 2.26255018 |
| 64 | Syringomyelia (HP:0003396) | 2.26255018 |
| 65 | Encephalitis (HP:0002383) | 2.25574039 |
| 66 | Abnormality of T cell number (HP:0011839) | 2.25068126 |
| 67 | Urticaria (HP:0001025) | 2.24845146 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.24575325 |
| 69 | Abnormal foot bone ossification (HP:0010675) | 2.24305031 |
| 70 | Ulnar bowing (HP:0003031) | 2.21973646 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.21833683 |
| 72 | IgM deficiency (HP:0002850) | 2.21796907 |
| 73 | Recurrent skin infections (HP:0001581) | 2.21412640 |
| 74 | Vasculitis (HP:0002633) | 2.21206560 |
| 75 | Limited elbow extension (HP:0001377) | 2.20372107 |
| 76 | Flat acetabular roof (HP:0003180) | 2.18669101 |
| 77 | Recurrent abscess formation (HP:0002722) | 2.17905617 |
| 78 | Pustule (HP:0200039) | 2.16912905 |
| 79 | Easy fatigability (HP:0003388) | 2.16219347 |
| 80 | Radial bowing (HP:0002986) | 2.15888555 |
| 81 | Increased connective tissue (HP:0009025) | 2.13701791 |
| 82 | Nemaline bodies (HP:0003798) | 2.12460293 |
| 83 | Distal arthrogryposis (HP:0005684) | 2.10834225 |
| 84 | Metaphyseal dysplasia (HP:0100255) | 2.10444754 |
| 85 | Irregular epiphyses (HP:0010582) | 2.09931631 |
| 86 | Dilatation of the ascending aorta (HP:0005111) | 2.08203111 |
| 87 | Premature rupture of membranes (HP:0001788) | 2.06768873 |
| 88 | Emphysema (HP:0002097) | 2.06721720 |
| 89 | Abnormality of the ischium (HP:0003174) | 2.05605466 |
| 90 | Hypochromic anemia (HP:0001931) | 2.03968410 |
| 91 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.02513099 |
| 92 | Mesomelia (HP:0003027) | 2.01639997 |
| 93 | Long clavicles (HP:0000890) | 2.01333277 |
| 94 | Cupped ribs (HP:0000887) | 2.00719403 |
| 95 | Broad palm (HP:0001169) | 2.00671741 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99375963 |
| 97 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99375963 |
| 98 | Sepsis (HP:0100806) | 1.97995172 |
| 99 | Episodic fever (HP:0001954) | 1.97597009 |
| 100 | Distal lower limb amyotrophy (HP:0008944) | 1.96859711 |
| 101 | Joint stiffness (HP:0001387) | 1.96763249 |
| 102 | Vascular tortuosity (HP:0004948) | 1.96130519 |
| 103 | Keratoconjunctivitis (HP:0001096) | 1.95946662 |
| 104 | Difficulty running (HP:0009046) | 1.95201767 |
| 105 | Papilloma (HP:0012740) | 1.94478773 |
| 106 | Verrucae (HP:0200043) | 1.94478773 |
| 107 | Gastrointestinal stroma tumor (HP:0100723) | 1.94389090 |
| 108 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.93751969 |
| 109 | Panhypogammaglobulinemia (HP:0003139) | 1.93412725 |
| 110 | Recurrent bacterial skin infections (HP:0005406) | 1.93280572 |
| 111 | Osteolytic defects of the hand bones (HP:0009699) | 1.92915326 |
| 112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92915326 |
| 113 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.92277898 |
| 114 | Abnormality of T cells (HP:0002843) | 1.91934198 |
| 115 | Persistence of primary teeth (HP:0006335) | 1.91447543 |
| 116 | Hypergammaglobulinemia (HP:0010702) | 1.90961872 |
| 117 | Muscle fiber splitting (HP:0003555) | 1.90762448 |
| 118 | Increased IgM level (HP:0003496) | 1.90132258 |
| 119 | Coxa vara (HP:0002812) | 1.89566023 |
| 120 | Polycythemia (HP:0001901) | 1.89524073 |
| 121 | Colitis (HP:0002583) | 1.89358607 |
| 122 | Abnormal vertebral ossification (HP:0100569) | 1.88314495 |
| 123 | Mitral valve prolapse (HP:0001634) | 1.86082278 |
| 124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.85741192 |
| 125 | Aneurysm (HP:0002617) | 1.85491836 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83425573 |
| 127 | Agammaglobulinemia (HP:0004432) | 1.83222462 |
| 128 | Osteomyelitis (HP:0002754) | 1.83005847 |
| 129 | Arterial thrombosis (HP:0004420) | 1.82599330 |
| 130 | Arterial tortuosity (HP:0005116) | 1.82421214 |
| 131 | Frequent falls (HP:0002359) | 1.82131964 |
| 132 | Shallow orbits (HP:0000586) | 1.80435105 |
| 133 | Platyspondyly (HP:0000926) | 1.79482462 |
| 134 | Hyporeflexia of lower limbs (HP:0002600) | 1.79444022 |
| 135 | Granulocytopenia (HP:0001913) | 1.78920045 |
| 136 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.78903635 |
| 137 | Bruising susceptibility (HP:0000978) | 1.77698965 |
| 138 | Flattened epiphyses (HP:0003071) | 1.77641426 |
| 139 | Leukocytosis (HP:0001974) | 1.77368434 |
| 140 | Disproportionate tall stature (HP:0001519) | 1.76999076 |
| 141 | Bowing of the arm (HP:0006488) | 1.76383598 |
| 142 | Bowed forearm bones (HP:0003956) | 1.76383598 |
| 143 | Restrictive lung disease (HP:0002091) | 1.76373024 |
| 144 | Dislocated radial head (HP:0003083) | 1.75970133 |
| 145 | Calcaneovalgus deformity (HP:0001848) | 1.75747978 |
| 146 | Lymphopenia (HP:0001888) | 1.75715638 |
| 147 | Bicuspid aortic valve (HP:0001647) | 1.75555015 |
| 148 | Round ear (HP:0100830) | 1.74859225 |
| 149 | Hepatosplenomegaly (HP:0001433) | 1.74236044 |
| 150 | Gastrointestinal inflammation (HP:0004386) | 1.73617563 |
| 151 | Slow saccadic eye movements (HP:0000514) | 1.73191360 |
| 152 | Slender build (HP:0001533) | 1.73171148 |
| 153 | Chronic sinusitis (HP:0011109) | 1.73107537 |
| 154 | Wormian bones (HP:0002645) | 1.72237961 |
| 155 | Papilledema (HP:0001085) | 1.72209081 |
| 156 | Facial diplegia (HP:0001349) | 1.72019877 |
| 157 | Inflammation of the large intestine (HP:0002037) | 1.71852422 |
| 158 | Thoracolumbar scoliosis (HP:0002944) | 1.71562166 |
| 159 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71528431 |
| 160 | Skin ulcer (HP:0200042) | 1.70235678 |
| 161 | Increased IgE level (HP:0003212) | 1.69772251 |
| 162 | Limb-girdle muscle atrophy (HP:0003797) | 1.69636976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.10676280 |
| 2 | RIPK4 | 3.29322759 |
| 3 | TRIB3 | 3.19422099 |
| 4 | TTN | 2.95358846 |
| 5 | EEF2K | 2.95198337 |
| 6 | PKN2 | 2.71186105 |
| 7 | STK10 | 2.57815393 |
| 8 | PRPF4B | 2.37990694 |
| 9 | JAK3 | 2.36010497 |
| 10 | LRRK2 | 2.27997481 |
| 11 | TGFBR2 | 2.27644701 |
| 12 | SMG1 | 2.20680946 |
| 13 | TNK2 | 2.16889426 |
| 14 | MAP3K10 | 2.16239867 |
| 15 | SIK3 | 2.15352058 |
| 16 | ZAP70 | 2.14907747 |
| 17 | ERN1 | 2.09024166 |
| 18 | KIT | 2.07031843 |
| 19 | TXK | 1.98237454 |
| 20 | MAP2K3 | 1.96605818 |
| 21 | TYK2 | 1.82530163 |
| 22 | FES | 1.71333603 |
| 23 | ITK | 1.67217482 |
| 24 | STK24 | 1.63410056 |
| 25 | FGFR4 | 1.60795533 |
| 26 | FLT3 | 1.59591298 |
| 27 | BTK | 1.56437349 |
| 28 | TIE1 | 1.55700331 |
| 29 | JAK1 | 1.53127383 |
| 30 | MARK2 | 1.50298560 |
| 31 | TEC | 1.48269233 |
| 32 | RPS6KA4 | 1.46668955 |
| 33 | CSF1R | 1.45293464 |
| 34 | KDR | 1.44385351 |
| 35 | TBK1 | 1.43569403 |
| 36 | PRKD2 | 1.43319422 |
| 37 | FGFR3 | 1.40947134 |
| 38 | RIPK1 | 1.39883173 |
| 39 | TGFBR1 | 1.33697756 |
| 40 | EPHB1 | 1.33536022 |
| 41 | GRK6 | 1.29929926 |
| 42 | TRPM7 | 1.27649808 |
| 43 | MAP3K3 | 1.26235423 |
| 44 | PTK6 | 1.25125408 |
| 45 | IKBKE | 1.23899254 |
| 46 | CDK12 | 1.20406512 |
| 47 | MAP3K6 | 1.19341803 |
| 48 | KSR2 | 1.19104582 |
| 49 | BMX | 1.19034195 |
| 50 | TESK1 | 1.18464320 |
| 51 | MAP3K11 | 1.17400960 |
| 52 | STK38 | 1.17163742 |
| 53 | NLK | 1.16738661 |
| 54 | HCK | 1.14400782 |
| 55 | CSK | 1.12086630 |
| 56 | MAPKAPK3 | 1.11434689 |
| 57 | EPHA2 | 1.07463669 |
| 58 | LCK | 1.04526076 |
| 59 | BLK | 1.03019227 |
| 60 | DYRK1B | 1.01616031 |
| 61 | PAK4 | 1.01352300 |
| 62 | SIK1 | 1.00413317 |
| 63 | SYK | 0.99446109 |
| 64 | MAP3K1 | 0.96407294 |
| 65 | FGR | 0.96273835 |
| 66 | TESK2 | 0.95647349 |
| 67 | DMPK | 0.95071513 |
| 68 | IRAK4 | 0.93896214 |
| 69 | DDR2 | 0.93537229 |
| 70 | PTK2B | 0.91951615 |
| 71 | CDC42BPA | 0.91901419 |
| 72 | MAP3K7 | 0.84795315 |
| 73 | RPS6KB2 | 0.83471659 |
| 74 | EPHB2 | 0.83003547 |
| 75 | CLK1 | 0.82449584 |
| 76 | PIM1 | 0.80845568 |
| 77 | MAP3K14 | 0.80810689 |
| 78 | MAP2K2 | 0.80628294 |
| 79 | MARK3 | 0.78525911 |
| 80 | YES1 | 0.77420074 |
| 81 | HIPK2 | 0.76699096 |
| 82 | PDGFRB | 0.76560554 |
| 83 | PDPK1 | 0.76355658 |
| 84 | CDK6 | 0.75919256 |
| 85 | TAOK1 | 0.75051365 |
| 86 | MAPK7 | 0.74931306 |
| 87 | PIK3CG | 0.74849525 |
| 88 | RPS6KA2 | 0.74795775 |
| 89 | ILK | 0.74494533 |
| 90 | ICK | 0.70924079 |
| 91 | PDGFRA | 0.70008339 |
| 92 | STK3 | 0.69003307 |
| 93 | MAP3K8 | 0.66891520 |
| 94 | TAOK2 | 0.66203242 |
| 95 | PDK1 | 0.65275329 |
| 96 | MAPK12 | 0.64885102 |
| 97 | FYN | 0.64761069 |
| 98 | IKBKB | 0.64244435 |
| 99 | CAMKK1 | 0.63395710 |
| 100 | CHUK | 0.62597971 |
| 101 | CDK4 | 0.61945056 |
| 102 | PIM2 | 0.61222018 |
| 103 | SGK3 | 0.60311403 |
| 104 | EPHA3 | 0.59925784 |
| 105 | NEK9 | 0.59263689 |
| 106 | MYLK | 0.53090474 |
| 107 | MATK | 0.52713301 |
| 108 | JAK2 | 0.51492056 |
| 109 | PRKCH | 0.51478710 |
| 110 | LYN | 0.50992460 |
| 111 | RPS6KA6 | 0.50134449 |
| 112 | ROCK2 | 0.49792910 |
| 113 | MAP3K13 | 0.48934871 |
| 114 | IRAK1 | 0.48357628 |
| 115 | PAK2 | 0.47966237 |
| 116 | SIK2 | 0.47145776 |
| 117 | MTOR | 0.46741490 |
| 118 | OBSCN | 0.46737640 |
| 119 | STK4 | 0.46332238 |
| 120 | IRAK2 | 0.43957742 |
| 121 | PRKG2 | 0.43624564 |
| 122 | KSR1 | 0.43189772 |
| 123 | MST4 | 0.42609645 |
| 124 | PRKD3 | 0.42265118 |
| 125 | FGFR1 | 0.42168269 |
| 126 | CDK19 | 0.42068280 |
| 127 | MAPKAPK2 | 0.41456137 |
| 128 | NME2 | 0.40226242 |
| 129 | MOS | 0.39852531 |
| 130 | RPS6KC1 | 0.38600649 |
| 131 | RPS6KL1 | 0.38600649 |
| 132 | PRKD1 | 0.38338107 |
| 133 | NEK2 | 0.37628356 |
| 134 | SCYL2 | 0.37266346 |
| 135 | MAPK4 | 0.36964899 |
| 136 | CDK9 | 0.36459786 |
| 137 | TYRO3 | 0.35454419 |
| 138 | BRD4 | 0.35208972 |
| 139 | MAPK15 | 0.35085675 |
| 140 | PTK2 | 0.33594292 |
| 141 | RET | 0.32570822 |
| 142 | PRKCQ | 0.32284422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.06891793 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14014107 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.06239233 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86833142 |
| 5 | Viral myocarditis_Homo sapiens_hsa05416 | 1.85862893 |
| 6 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.85130962 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.79793451 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79777906 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.79601646 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.78813872 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76698401 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.72533982 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66315873 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65384422 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64543612 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63158729 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.60033320 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.59690809 |
| 19 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.59536541 |
| 20 | Focal adhesion_Homo sapiens_hsa04510 | 1.56243242 |
| 21 | Platelet activation_Homo sapiens_hsa04611 | 1.53250833 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.52857751 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46951412 |
| 24 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.40631993 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.40421078 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.37274717 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34720894 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.31843211 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31616916 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.27777563 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26201349 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24508506 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24410593 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23688125 |
| 35 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.23026485 |
| 36 | HTLV-I infection_Homo sapiens_hsa05166 | 1.20674012 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.19866024 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.17826357 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.17745506 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.15718598 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.15213943 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14897863 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12787386 |
| 44 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.11877342 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.10203590 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08072365 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07840196 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07517667 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.06961562 |
| 50 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.03383374 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03340343 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03142563 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01189992 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00888229 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00857244 |
| 56 | Colorectal cancer_Homo sapiens_hsa05210 | 0.98941591 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.96850314 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.96716801 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96413742 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96285744 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96102127 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.93974183 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93783931 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92444983 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92091793 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.91783667 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.91546780 |
| 68 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.90474172 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.89740288 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88788359 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88290703 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88234015 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87834365 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85434605 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83311071 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.81884810 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81675499 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80983265 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80960687 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80014637 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79359984 |
| 82 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.79078083 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.78723314 |
| 84 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.78666534 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.78142950 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.77847293 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77193348 |
| 88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76940511 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76912088 |
| 90 | Base excision repair_Homo sapiens_hsa03410 | 0.72643327 |
| 91 | DNA replication_Homo sapiens_hsa03030 | 0.72183700 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71278958 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70815349 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69459684 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68434689 |
| 96 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68385021 |
| 97 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68035074 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67499405 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67227855 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66585063 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65934736 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65844401 |
| 103 | Axon guidance_Homo sapiens_hsa04360 | 0.65366026 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.64749031 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64614993 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.63320484 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.63197824 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63154581 |
| 109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62805037 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62382300 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62196542 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59555015 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58232558 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58216669 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58202995 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55942054 |
| 117 | Cell cycle_Homo sapiens_hsa04110 | 0.54023194 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53003265 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51935474 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.51571158 |
| 121 | Allograft rejection_Homo sapiens_hsa05330 | 0.50385302 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.50078860 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49722739 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.49429140 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49222379 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46582717 |

